 The FDA has approved the use of Eli Lilly And Cos NYSE:LLY Lyumjev insulin lispro-aabc injection 100 unitsmL with Insulet Corporations NASDAQ:PODD insulin management systems. Lyumjev, approved by the FDA in June 2020, is a formulation of insulin lispro to speed insulin absorption into the bloodstream. 